Results of a new trial with clevidipine, an investigational calcium-channel blocker with an ultrashort half-life of less than one minute, show the drug has promise in patients presenting to the emergency room with an acute severe episode of hypertension. Heartwire
Despite Task Force recommendations against screening for AAA in women, a study suggests screening in women older than age 65 years and in women with a history of heart disease or smoking. Medscape Medical News
Researchers say a 24-year cohort study provides some of the best evidence of the enduring benefit of low-sodium/plant-food-rich diets, given the impossibility of conducting a long-term clinical trial. Medscape Medical News
Investigators suggest that lower revascularization rates in DES-treated vs bare-metal-stent-treated patients may have driven the improved survival, but they also emphasize that the real message is the lack of signal of harm. Heartwire
